Close
Close
Treatment Database
(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide
Trade Name not avaiable
Orphan Indication Paroxysmal nocturnal hemoglobinuria
USA Market Approval
USA Designation Date 02-11-2017
Sponsor Achillion Pharmaceuticals, Inc
300 George Street
New Haven, Connecticut, 06511
More about Hemoglobinuria
Free Newsletter
Videos
by Abidemi Uruejoma
12 views
by Abidemi Uruejoma
12 views
by Abidemi Uruejoma
42 views
by Abidemi Uruejoma
92 views